在新冠肺炎病例體內病毒清除之前,不建議使用高流量鼻套管或非侵入性呼吸器治療,尤其是重症或因新冠肺炎病導致急性呼吸窘迫症候群。

(財團法人國家衛生研究院 蔡慧如博士摘要整理)

As of Feb 27, 2020, coronavirus disease 2019 (COVID-19) has affected 47 countries and territories around the world.
 
 Xiaobo Yang and colleagues
 
 described 52 of 710 patients with confirmed COVID-19 admitted to an intensive care unit (ICU) in Wuhan, China. 29 (56%) of 52 patients were given non-invasive ventilation at ICU admission, of whom 22 (76%) required further orotracheal intubation and invasive mechanical ventilation. The ICU mortality rate among those who required non-invasive ventilation was 23 (79%) of 29 and among those who required invasive mechanical ventilation was 19 (86%) of 22.
 
Jonathan Chun-Hei Cheung and colleagues
 
 do not recommend use of a high-flow nasal cannula or non-invasive ventilation until the patient has viral clearance. Supporting the recommendation of the authors, I would like to add some points in relation to the use of high-flow nasal oxygen therapy and non-invasive ventilation in patients with COVID-19 infection:

Author:

Link:

Author:Silvio A Ñamendys-Silva
原文連結:https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30110-7/fulltext